Comparison - IDXAD - OTC PK

Weiss Ratings	IDXAD - OTC PK	Click to Compare	Click to Compare	Click to Compare
Rating	D
Reward Index	Very Weak
Risk Index	Weak
Risk Grade	D
Reward Grade	E

Rating Factors	IDXAD - OTC PK	Click to Compare	Click to Compare	Click to Compare
Dividend Index	--
Growth Index	Fair
Efficiency Index	Very Weak
Solvency Index	Good
Total Return Index	Very Weak
Volatility Index	Weak

Beta / Standard Deviation	IDXAD - OTC PK	Click to Compare	Click to Compare	Click to Compare
Beta	25.97

Price History	IDXAD - OTC PK	Click to Compare	Click to Compare	Click to Compare
7-Day Total Return	0.00%
30-Day Total Return	400.00%
60-Day Total Return	400.00%
90-Day Total Return	400.00%
Year to Date Total Return	400.00%
1-Year Total Return	-99.29%
2-Year Total Return	-99.75%
3-Year Total Return	-99.90%
5-Year Total Return	-99.62%
52-Week High % Change	-99.00%
52-Week Low % Change	400.00%

Price	IDXAD - OTC PK	Click to Compare	Click to Compare	Click to Compare
52-Week High Price	$0.10
52-Week Low Price	$0.00
52-Week Low Price (Date)	Mar 27, 2024
52-Week High Price (Date)	Jun 17, 2024

Valuation	IDXAD - OTC PK	Click to Compare	Click to Compare	Click to Compare
Market Cap	3.29M
Enterprise Value	1.56M
Price/Earnings (TTM)	--
Earnings Per Share (TTM)	-0.06
Earnings Per Share Growth	-49.73%
Price/Earnings To Growth	--
Price/Sales (TTM)	0.24
Price/Book (Q)	0.08
Enterprise Value/Revenue (TTM)	1.14
Price	$0.00
Enterprise Value/EBITDA (TTM)	-0.08
Enterprise Value/EBIT	-0.07
Market Cap Category	Nano Cap

Dividends and Shares	IDXAD - OTC PK	Click to Compare	Click to Compare	Click to Compare
Shares Outstanding	314.07M
Dividend Yield	--
Div. Per Share (Most Recent)	--
Dividend Per Share (TTM)	--
Payout Ratio (TTM)	--
Dividend Per Share (Most Recent)	--

Company Info	IDXAD - OTC PK	Click to Compare	Click to Compare	Click to Compare
Phone Number	47 67 83 91 19
Address	--
Website	www.idexbiometrics.com
Country	Norway
Year Founded	1996

Profitability	IDXAD - OTC PK	Click to Compare	Click to Compare	Click to Compare
Operating Margin (TTM)	-1,637.76%
Profit Margin	-1,203.61%

Management Effectiveness	IDXAD - OTC PK	Click to Compare	Click to Compare	Click to Compare
Return on Assets	-80.73%
Return on Equity	--

Income Statement	IDXAD - OTC PK	Click to Compare	Click to Compare	Click to Compare
Revenue (TTM)	1.30M
Total Revenue (TTM)	1.30M
Revenue Per Share	$0.00
Gross Profit (TTM)	-314.00K
EBITDA (TTM)	-19.38M
EBIT (TTM)	-21.29M
Net Income (TTM)	-15.65M
Net Income Avl. to Common (TTM)	-15.65M
Total Revenue Growth (Q YOY)	-93.89%
Earnings Growth (Q YOY)	119.35%
EPS Diluted (TTM)	-0.06
EPS Diluted Growth (Q YOY)	114.33%

Balance Sheet	IDXAD - OTC PK	Click to Compare	Click to Compare	Click to Compare
Cash and Short-Term Inv. (Q)	1.08M
Cash Per Share (Q)	$0.00
Total Current Assets (Q)	10.56M
Total Preferred Equity (Q)	--
Total Equity (Q)	5.73M
Current Ratio (Q)	2.163
Book Value Per Share (Q)	$0.01
Total Assets (Q)	12.99M
Total Current Liabilities (Q)	4.88M
Total Debt (Q)	521.00K
Total Liabilities (Q)	7.26M
Total Common Equity (Q)	5.73M

Cash Flow	IDXAD - OTC PK	Click to Compare	Click to Compare	Click to Compare
Cash from Investing (TTM)	310.00K
Cash from Financing (TTM)	14.97M
Net Change in Cash (TTM)	-2.58M
Levered Free Cash Flow (TTM)	-10.77M
Cash from Operations (TTM)	-17.87M